Feed OSUR
OS

OraSure Technologies, Inc.

OSUR · NASDAQ

$3.69 +2.36% (+$0.08)
1M -3.40%
Market Cap $254.1M
P/E Ratio -
Div. Yield -
ROE 14.73%

Bulios Fair Price

$1.86

49.6% downside

Trenutna cena

$3.69

Podcenjeno Poštena vrednost Precenjeno

Po podatkih Bulios Fair Price je delnica OSUR trenutno precenjena glede na svojo tržno ceno. Kako deluje?

Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?

Piotroski F-Score Moderate
4/9
Valuation
86 /100
Cheap
P/S 2.26x
P/B 0.80x
P/E N/A
Growth
3 /100
Declining
Rev. growth 33.29%
Book val. growth 2.21%
EPS growth N/A
Profitability
16 /100
Weak
Gross margin 41.38%
Net margin 43.70%
Op. margin 44.75%
Quality
4 /100
Poor
ROIC 15.02%
ROE 14.73%
ROA 13.63%
Debt
100 /100
Low
Debt/Equity 0.04x
Current ratio 8.88x
Int. coverage N/A
Stability
32 /100
Unstable
Beta 0.99x
Rev. volatility 30.40%
EPS volatility 344.56%

Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več

Vprašajte StockBota o OSUR
Online

O podjetju

OraSure Technologies, Inc. (OSUR) is a company focused on diagnostic solutions and testing in the healthcare sector. With over two decades of history, OraSure Technologies is a leading provider of technologies for non-invasive diagnostics and monitoring of infectious diseases and other health conditions. Their innovative products include rapid tests, genetic analyses, and laboratory diagnostics. The company is also engaged in combating the spread of diseases and supports health prevention and care. OraSure Technologies, Inc. (OSUR) shares could be suitable for investors who want to contribute to the development of advanced diagnostic technologies and the improvement of healthcare.

V vašem jeziku še ni na voljo, zato je besedilo v angleščini.

Sector

Healthcare

Industry

Medical - Instruments & Supplies

CEO

Carrie Eglinton Manner

Employees

500

Headquarters

Bethlehem

Prihajajoči dogodki

04 NOV.

Earnings

Upcoming earnings report

43d

Uporabljamo nujne piškotke za delovanje spletnega mesta in izbirne analitične piškotke za merjenje uporabe. Preberite naš Pravilnik o zasebnosti.